Bisphosphonates, healthcare professionals and oral health
MetadataShow full item record
Objective: General medical and den tal practitioner and pharmacists all encounter patients on bis-phosphonates and as such require adequate knowledge regarding osteonecrosis of the jaw, a potentialcomplication associated with its use. The cross-sectional study investigated perceived implications of andattitudes towards bisphosphonate use in oral health among general medical and dental practitioners andpharmacists.Materials and methods: Medical and dental practitioners and pharmacists registered in Victoria, Aus-tralia, completed an online survey (SurveyMonkey©). Data analysis consi sted of chi-square tests withsigniﬁcance as p < 0.05.Results: One hundred and thirty six doctors (general medical practitioners, GMPs), 283 de ntists (GDPs)and 26 pharmacists (PHs) participated. 70, 38 and 80%, respectively, reviewed patients prescribed bis-phosphonates (BPs). GM Ps (88%), GDPs (76%) and PHs (85%) were aware of osteonec rosis of the jaws(ONJ). GMPs (76%) and PHs (100%) advised patients to inform dentists. GMPs (45%) referred patientsfor dental assessments prior to commencing BPs with 71.9% of GDPs received such referr als. In terms ofavailable informati on on oral health and BPs, GM Ps (56%), GDPs (50%) and PH (53.8%) were eitherunsure any existed or reported receiving sufﬁcient information.Conclusions: Discrepancies exist amongst different healthcare professionals in terms of BP use and oralhealth, and common consensus guidelines are warranted.
Dentistry not elsewhere classified